InsidersTradesSigma
Track the 광동제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Food & Beverage sector, 광동제약 has published 42 reports. Market capitalisation: €300bn. The latest transaction was reported on 14 April 2026 (Other). Among the most active insiders: 최성원. The full history is openly available.
41
Insider Decl.
n/a
Thresholds
€76,292
7 ops.
Buy Volume
n/a
1 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,128 of 29,055 companies
50.9
score / 100
Value74
Quality28
FCF yld18%
Earn yld6.6%
EV/EBITDA10.3x
ROE3.5%
Gross mgn18%
Net mgn1.3%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 April 2026
Declarations42 total
Other
25 of 42 declarations
Acerca de 광동제약
광동제약 es una empresa surcoreana que se especializa en la fabricación de productos farmacéuticos y de salud. Cotiza en el mercado XKRX.